Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Karyopharm Therapeutics Inc. (KPTI) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Karyopharm Therapeutics Inc. (KPTI) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 13th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 13th:
Karyopharm Therapeutics Inc. (KPTI - Free Report) : This oncology-focused pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Karyopharm Therapeutics Inc. Price and Consensus
Karyopharm Therapeutics Inc. price-consensus-chart | Karyopharm Therapeutics Inc. Quote
Karyopharm Therapeutics’ shares gained 9.7% over the last one month more than S&P 500’s gain of 3.1%. The company possesses a Momentum Score of A.
Karyopharm Therapeutics Inc. Price
Karyopharm Therapeutics Inc. price | Karyopharm Therapeutics Inc. Quote
PLDT Inc. (PHI - Free Report) : This telecommunications company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
PLDT Inc. Price and Consensus
PLDT Inc. price-consensus-chart | PLDT Inc. Quote
PLDT’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.
PLDT Inc. Price
PLDT Inc. price | PLDT Inc. Quote
Exact Sciences Corporation (EXAS - Free Report) : This molecular diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
Exact Sciences Corporation Price and Consensus
Exact Sciences Corporation price-consensus-chart | Exact Sciences Corporation Quote
Exact Sciences’ shares gained 19.8% over the last one month. The company possesses a Momentum Score of A.
Exact Sciences Corporation Price
Exact Sciences Corporation price | Exact Sciences Corporation Quote
AquaVenture Holdings Limited : This water-as-a-service solutions provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.
AquaVenture Holdings Ltd. Price and Consensus
AquaVenture Holdings Ltd. price-consensus-chart | AquaVenture Holdings Ltd. Quote
AquaVenture’s shares gained 26.7% over the last one month. The company possesses a Momentum Score of B.
AquaVenture Holdings Ltd. Price
AquaVenture Holdings Ltd. price | AquaVenture Holdings Ltd. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>